NCT03309033
Extended Follow-up of Women Who Received One, Two, and Three Doses of the HPV Vaccine in the Costa Rica Vaccine Trial (CVT), ESCUDDO-CVT Study
StatusActive, Not Recruiting
PhaseNot specified
Primary completion
At risk: Enrollment reduced 100%.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
The 50 most recent of 281 versions: 34 with changes below, 16 re-verified with no change. See every version on ClinicalTrials.gov ↗
- Notable Enrollment increased: 1 → 946 participants
- Notable Enrollment reduced: 946 → 1 participants
- Notable Eligibility criteria expanded, about 2 words
- Minor Study completion pushed from Feb 28, 2026 to Dec 28, 2028v276
- Minor Enrollment target: estimated 991 to confirmed 946
- Primary completion date changed from estimate of Feb 28, 2026 to Mar 5, 2026
- Study completion date: Feb 28, 2026 to Dec 28, 2028
Show 29 earlier versionsHide 29 earlier versions
- Minor Enrollment target: 900 to 991
- Interventions: Biospecimen Collection (Procedure), Laboratory Biomarker Analysis (Other), Questionnaire Administration (Other) to Biospecimen Collection (Procedure), Questionnaire Administration (Other)
- Study description expanded, about 65 words
- Study title expanded, about 3 words
- Notable Primary and study completion dates: Dec 31, 2022 to Feb 28, 2026v268
- Minor Site details revisedv264
- Minor Study site revisedv260
Notable Trial status: Terminated to Active, Not Recruitingv259 Show 4 more changesShow less
- Primary and study completion dates: May 13, 2020 to Dec 31, 2022
- Enrollment target: 869 to 900
- Start date: Jul 18, 2018 to Jul 2, 2018
- Interventions: Biospecimen Collection (Procedure), Laboratory Biomarker Analysis (Other), Questionnaire Administration (Other)
- Stopped Trial status: Active, Not Recruiting to Terminated Sponsor's reason: NIH is not engaged in human subjects research
- Primary and study completion dates changed from estimate of Dec 31, 2022 to May 13, 2020
- Minor Trial status: Enrolling by Invitation to Active, Not Recruitingv257
- Notable Enrollment target: 85 to 869
- Start date: Jul 2, 2018 to Jul 18, 2018
- Minor Start date changed from estimate of Oct 23, 2018 to Jul 2, 2018v252
- Minor Start date: Oct 22, 2018 to Oct 23, 2018v251
- Minor Start date: Oct 19, 2018 to Oct 22, 2018v250
- Minor Start date: Oct 18, 2018 to Oct 19, 2018v249
- Minor Start date: Oct 17, 2018 to Oct 18, 2018v248
- Minor Start date: Oct 16, 2018 to Oct 17, 2018v247
- Minor Start date: Oct 15, 2018 to Oct 16, 2018v246
- Minor Start date: Oct 12, 2018 to Oct 15, 2018v245
- Minor Start date: Oct 11, 2018 to Oct 12, 2018v244
- Minor Start date: Oct 10, 2018 to Oct 11, 2018v243
- Minor Start date: Oct 9, 2018 to Oct 10, 2018v242
- Minor Start date: Oct 8, 2018 to Oct 9, 2018v241
- Minor Start date: Oct 5, 2018 to Oct 8, 2018v240
- Minor Start date: Oct 4, 2018 to Oct 5, 2018v239
- Minor Start date: Oct 3, 2018 to Oct 4, 2018v238
- Minor Start date: Oct 2, 2018 to Oct 3, 2018v237
- Minor Start date: Oct 1, 2018 to Oct 2, 2018v236
- Minor Start date: Sep 28, 2018 to Oct 1, 2018v235
- Minor Start date: Sep 27, 2018 to Sep 28, 2018v234
- Minor Start date: Sep 26, 2018 to Sep 27, 2018v233
- Minor Start date: Sep 25, 2018 to Sep 26, 2018v232
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Seropositivity
Timeframe: Up to 20 years after initial vaccination
Change in antibody levels
Timeframe: Between years 11 and 20 after initial vaccination
Proportion of individuals who serorevert
Timeframe: Between years 11 and 20 after initial vaccination
Arms and interventions
Observational (questionnaire, biospecimen collection)
Patients complete a short questionnaire regarding risk factors for HPV infection and undergo collection of blood samples for testing HPV16 and HPV18 levels on study.
Procedures: Biospecimen Collection
Other: Questionnaire Administration
Sites
1 site in 1 country
- Agencia Costarricense de Investigaciones Biomédicas (ACIB)Liberia, Guanacaste Province, Costa Rica